Why the study?
Do tricyclic antidepressants reduce sudden death in depressed patients with preexisting arrhythmias or post-myocardial infarction?
Do tricyclic antidepressants reduce sudden death in depressed patients with preexisting arrhythmias or post-myocardial infarction?
Answers are grounded in this paper and cite their sources.
The safety of tricyclic antidepressants in cardiac patients is reconsidered, highlighting that their class I antiarrhythmic-like effects may not be beneficial post-myocardial infarction.
IN 1977, we first reported the antiarrhythmic effect of imipramine hydrochloride.¹Prior to that time, physicians generally believed that the tricyclic antidepressants (TCAs) caused arrhythmia. That belief stemmed from the propensity of overdoses of these drugs to provoke arrhythmias.²However, it subsequently became apparent, both from our studies³⁻⁶and the work of others,⁷that at plasma concentrations therapeutic for depression,⁸TCAs suppress arrhythmias, and their cardiac effects closely resemble those of class I antiarrhythmic drugs.⁹,¹⁰Until recently, it was our belief that depressed patients with preexisting arrhythmias would benefit from the antiarrhythmic effect of TCAs.¹¹,¹²Unfortunately, recent studies indicate that this opinion may need to be revised. Ventricular premature depolarizations (VPDs) are a well-documented risk factor for sudden death after myocardial infarction (MI)¹³,¹⁴and the assumption had been that drugs that suppress VPDs would reduce this associated mortality.
No takes yet. Share an insight, caveat, or question.
Alexander H. Glassman (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: